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Abstract
Background: Traumatic brain injury (TBI) is the main cause of mortality and severe morbidity in cyclists admitted to
Dutch emergency departments (EDs). Although the use of bicycle helmets is an effective way of preventing TBI, this
is uncommon in the Netherlands. An option to increase its use is through a legal enforcement. However, little is
known about the cost-effectiveness of such mandatory use of helmets in the Dutch context.
The current study aimed to assess the cost-effectiveness of a law that enforces helmet use to reduce TBI and TBI-
related mortality.
Methods: The cost-effectiveness was estimated through decision tree modelling. In this study, wearing bicycle
helmets enforced by law was compared with the current situation of infrequent voluntary helmet use. The total
Dutch cycling population, consisting of 13.5 million people, was included in the model. Model data and parameters
were obtained from Statistics Netherlands, the National Road Traffic Database, Dutch Injury Surveillance System, and
literature. Effects included were numbers of TBI, death, and disability-adjusted life years (DALY). Costs included were
healthcare costs, costs of productivity losses, and helmet costs. Sensitivity analysis was performed to assess which
parameter had the largest influence on the incremental cost-effectiveness ratio (ICER).
Results: The intervention would lead to an estimated reduction of 2942 cases of TBI and 46 deaths.
Overall, the incremental costs per 1) death averted, 2) per TBI averted, and 3) per DALY averted were estimated at
1) € 2,002,766, 2) € 31,028 and 3) € 28,465, respectively. Most favorable were the incremental costs per DALY in the
65+ age group: € 17,775.
Conclusions: The overall costs per DALY averted surpassed the Dutch willingness to pay threshold value of € 20,
000 for cost-effectiveness of preventive interventions. However, the cost per DALY averted for the elderly was
below this threshold, indicating that in this age group largest effects can be reached. If the price of a helmet would
reduce by 20%, which is non-hypothetical in a situation of large-scale purchases and use of these helmets, the
introduction of this regulation would result in an intervention that is almost cost-effective in all age groups.
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Background
In the Netherlands, cycling is a common mode of trans-
portation and bicycle trips account for up to 28% of all
transfers made [1]. Dutch people cycle a mean daily dis-
tance of 2.9 km and over 40% of inhabitants cycle at
least once a day, the highest level of any country in the
European Union [2, 3]. Although the level of road safety
in the Netherlands is high, roughly 78,400 injuries per
year are treated at an emergency department (ED), of
which 13,300 (17%) result in hospital admissions [4].
Even though the total number of bicycle related fatalities
declined between 1996 (239) and 2016 (189), the num-
ber of bicycle related deaths remained at a high level
with an average number of 189 casualties in the last 5
years [5]. In 1996, 20% of all traffic deaths were bicycle
related, increasing to 30% in 2016 [5].
Traumatic brain injury (TBI) is the main cause of severe
morbidity and mortality after an accident involving bicy-
clists. More specifically, 32% out of all hospitalized cyclists
with severe injury has a head or brain injury [1, 4, 6]. The
incidence of bicycle related TBI treated at the ED has in-
creased with 54% between 1998 and 2012, while the over-
all incidence of bicycle related injuries treated at the ED
remained relatively stable in that period. In 2012, bicycle
related TBI was treated 43 times per 100,000 persons in
the ED and resulted in subsequent hospitalization in 64%
of the TBI cases [6].
Most survivors of this form of injury remain impaired for
life. TBI has been associated with a decline in cognitive cap-
acity, long lasting physical disability and handicap, and the
development of mental illness [7–9]. The consequences of
TBI often prohibit survivors from returning to full employ-
ment, reduce their quality of life, and have been linked to
an increased risk of suicide [10–13]. Scholten et al. valued
the mean healthcare costs and costs due to productivity loss
resulting from bicycle related TBI at € 19,620 per case for
the Netherlands, of which € 4940 healthcare costs and € 14,
680 productivity losses per case. Total costs were estimated
at 74.5 million euros in 2012 [6].
About 75% of all bicycle-related head injuries are
caused by single-bicycle accidents, i.e. accidents without
any motorized vehicles involved. In most cases this in-
volves falls or collisions with an obstacle [14]. Polinder
et al. (2016) identified these injuries as a priority area for
prevention [15]. The use of bicycle helmets has been
found to be an effective measure of preventing head and
brain injuries, especially in the case of these single-
bicycle accidents [16–19]. It is associated with a 51% re-
duction in odds for head injury, according to the most
recent and comprehensive systematic review on the sub-
ject [18]. Several countries have introduced legislation,
which enforces the use of helmets. Examples are Spain,
Sweden, Australia, New Zealand, certain states in
Canada, and the United States [17]. However, many
countries only require children to wear helmets. A re-
view of population-based studies that compare injury
data before and after the introduction of legislation that
enforces use of bicycle helmets found decreases in head
injuries and mortality in certain parts of Canada and the
United States [17]. However, some other similar studies
found only a small or no obvious effect of legislation on
number of injuries in New Zealand and certain parts of
Australia and Canada [20, 21].
Bicycle helmets are not mandatory in the Netherlands
and are generally only used by young children, mountain
bikers and racing cyclist [22]. According to a survey
commissioned by the Royal Dutch Touring Club, 73% of
adults and 84% of children under 17 never wear a hel-
met [23]. Although a considerable amount of research
into the efficacy of both the bicycle helmet and legisla-
tion that enforces its use has been performed, the cost-
effectiveness of such a law is unknown in the Dutch
context. The current research aims to explore the cost-
effectiveness of mandatory helmet use by comparing
costs and benefits of legislation with the costs and bene-
fits of the existing situation, i.e. voluntary helmet use in
a small part of all cyclists. This study can support
decision-making concerning a legalization to prevent bi-
cycle related TBI and death [24, 25].
Methods
Study design
The cost-effectiveness of legislation that enforces the use
of bicycle helmets was assessed through a decision-tree
model based on parameters obtained from the literature
and several databases. According to the Dutch guideline
for economic evaluations, a societal perspective was
used, implying that not only healthcare costs but also
non-healthcare costs such as cost of lost productivity,
were included [26].
The model had a lifetime horizon and compared the
cost and effects of the status quo, voluntary helmet use,
with the cost and effects of the intervention, mandatory
helmet use for all cyclists regardless of age.
In this economic evaluation, behavioral changes as a
result of the compulsory wearing of a helmet were not
taken into account because conclusive evidence on such
behavioral changes were not available.
Study population
The model contained a cohort that consists of all Dutch
cyclists that use a non-racing or non-mountain bike, i.e.
users of a utility bicycle. It was assumed that users of ra-
cing and mountain bikes are also users of the utility bi-
cycle. This type of bicycle is most common for daily use
in the Netherlands and will hereafter simply be referred
to as ‘bicycle‘. The total number of cyclists was retrieved
from Statistics Netherlands [27]. Data on active traffic
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participants were available for specific age groups in the
year 2016 and were corrected for population growth in
2017 (base year) in the corresponding age groups [28].
The resulting total number of approximately 13.5 mil-
lion cyclists match the raw estimate given by the Na-
tional Road Traffic Database [29]. Cyclists were divided
into three age groups: up to 15 years, between 15 and 65
years, and 65 years and older.
Intervention and comparator
The intervention under analysis is a hypothetical law im-
posing everyone in the Netherlands to wear a helmet
when riding a utility bicycle. The comparator is the
current situation of only voluntary helmet use.
Model parameters
a. TBI-related disease burden without a helmet law,
the current situation
Age specific estimates of bicycle-related TBI incidence
and mortality were obtained from the Dutch Injury Sur-
veillance System (LIS) and the mortality statistics of
Statistics Netherlands (Table 1) [30, 31]. The LIS is based
upon 13 geographically distributed Emergency Depart-
ments (EDs) in the Netherlands, resulting in a representa-
tive 12% sample of injury-related ED visits. Age specific
estimates on DALYs following bicycle related TBI were
obtained from the Dutch Burden of Injury Model [32, 33].
These were specified as years lived with disability (YLD)
for people that survived bicycle related TBI and years of
life lost (YLL) for people that died due to bicycle related
TBI. The disability weights for temporary and hospitalized
brain injury were 0.090 and 0.241, respectively [34].
All data used from the Dutch Injury Surveillance
System, Dutch Burden of injury Model, and national
mortality statistics relate specifically to users of utility
bicycles in 2017. The annual probability of having TBI
was calculated by dividing the incidence of TBI by the
total number of cyclist within each age group (≤14, 15–
64, ≥65 year). Because of the very low voluntary helmet
use in the country, it was assumed that none of the cases
with TBI had worn a helmet. The probability of
mortality due to bicycle related TBI was calculated by
dividing the mortality by the incidence of TBI within
each age group.
Table 1 Model parameters, not specified by age group
Model parameters Value (registered cases TBI on ED) Source
Incidence of TBI (number of cases) 8016 Dutch Injury Surveillance System
TBI related mortality (number of cases) 124 CBS cause of death statistics
Years Lived with Disability after TBI (mean value) 6649 Dutch Burden of Injury Model
Years of life lost following TBI (mean value) 2089 Dutch Burden of Injury Model
Disability-adjusted life years (sum of YLL and YLD) 8738 Dutch Burden of Injury Model
Number of cyclists 13,468,742 Computed with data from CBS Statline
Helmet efficacy (RR: TBI with helmet vs. without helmet) 0.583 Computed with data from existing literature
Mean current helmet use rate 2% Dutch Injury Surveillance System
Mean helmet use rate following legislation 88% Computed with data from existing literature
Risk of TBI when helmeted 0.000347 Model outcome
Risk of TBI when unhelmeted 0.000595 Model outcome
Risk of death for TBI victim 0.015493 Model outcome
Mean medical costs per person with TBI € 4335 Model outcome
Incidence of work absenteeism* after TBI (number of cases) 2820 Model outcome
Mean work absenteeism costs* per person € 11,252 Model outcome
Mean working-days absent 36 Model outcome
Mean productivity loss due to mortality* € 12,054 Model outcome
Friction period 101 days Guideline [26]
Mean number of working hours per week 31 h CBS Statline
Net labor participation 75.80% CBS Statline
Mean wage per hour € 35.55 Manual for Costing Research, corrected for inflation
Mean helmet costs per year € 10 Estimate (see text)
Work absenteeism costs and productivity loss were calculated with the friction-cost method
*Only for age group 15–65 years
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b. Helmet use
An estimate on bicycle helmet efficacy was obtained
from a recent and comprehensive review and meta-
analysis [18]. As this estimate is presented as an odds ra-
tio (OR), it was recalculated into a relative risk with the
following equation: RR =OR (1− Pref) + (Pref ∗OR), where
Pref stands for the prevalence of TBI in the group not
wearing a helmet [35].
The overall helmet-wearing rate of all injured cyclists
that were registered in the Dutch Injury Surveillance Sys-
tem was obtained (2%). This rate was also taken as the
helmet-wearing rate in the general population. Estimates
on compliance to mandatory bicycle helmet use in other
countries were obtained by combining data from litera-
ture. Helmet wearing rates following introduction of legis-
lation in New Zealand, Canada, the United States, and
Australia were used [21, 36–39]. In case of several esti-
mates being available for a single country, the mean
helmet-wearing rate for that country was calculated. The
mean helmet-wearing rate over all countries was added to
the helmet-wearing rate in the Netherlands following the
introduction of the mandatory helmet for moped drivers
in 1975 and the mean of those two variables was consid-
ered the projected helmet-wearing rate.
c. TBI-related disease burden following legislation
Calculations were as follows:
 Probability of having TBI for helmet wearers was
calculated by multiplying the baseline probability of
acquiring TBI as a bicyclist with the relative risk
(RR) of TBI for helmet wearers.
 Incidence of TBI for helmet wearers was obtained
by multiplying the projected helmet-wearing rate
with the total number of cyclists for a specific age
group. This group of helmet wearers was then
multiplied with the probability of having TBI for
helmet wearers.
 Incidence of TBI for non-helmet wearers was
obtained by multiplying the projected group of non-
helmet wearers with the probability of having TBI
for non-helmet wearers.
 Mortality was calculated by multiplying the bicycle
related TBI incidence with the probability of
mortality due to bicycle related TBI.
 YLD was calculated by multiplying the YLD in the
situation without a helmet law with the ratio of the
incidence of TBI in the situation with the helmet
law to the incidence of TBI in the situation without
the helmet law.
 YLL was calculated by multiplying the YLL in the
situation without a helmet law with the ratio of the
mortality in the situation with the helmet law to the
mortality in the situation without mandatory helmet
use.
Costs
The types of costs that were included in the model were
healthcare costs, costs due to lost productivity for both
people that survived TBI and for people that died from TBI,
and the annual cost of purchasing helmets. All costs were
expressed in 2017 euros.
a. Healthcare costs
Treatment costs of bicycle related TBI were obtained
from the Dutch Burden of Injury Model and included gen-
eral practitioner care, ambulance transport, hospital,
physiotherapy, home care and domestic help, nursing
homes, and rehabilitation care. These costs occurred
within the first year after the injury and were assumed an
acceptable representation of the total treatment costs. No
data are available for the health care costs after year 1.
Total treatment costs for survivors under the helmet law
condition were calculated by multiplying the projected in-
cidence of TBI with the mean treatment costs per TBI.
b. Productivity losses
The loss of productivity of people that survived TBI
were also obtained from the Dutch Burden of Injury
Model and were calculated using the friction-cost
method, as advised by the Dutch guidelines for health
economic evaluation [26]. Only people of working age
were eligible to incur this type of cost. The friction cost
period was converted into working hours and multiplied
by the mean productivity costs per hour for a working
person in 2017 [26, 40–42]. Total productivity losses for
survivors under the helmet law condition are obtained
by multiplying the projected incidence of TBI with the
mean productivity losses for survivors. Total productiv-
ity losses for people that have died were obtained by
multiplying the projected mortality with the mean prod-
uctivity losses for this group.
c. Helmet costs
The mean bicycle helmet price was estimated in the
same way as was done in German cost-benefit-research
[43]. The cost of the cheapest helmet of good quality in
the most recent review of ‘Stiftung Warentest’ (con-
sumer product tests) was used and was indexed to Euros
2017 [44–46]. The German figures were used because of
the large market share and the most recent data.
The mean recommended retail price for the twelve
best-selling helmets on www.amazon.de was also used.
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The mean of these two prices was taken and corrected
for Dutch price levels [47]. Everyone from the age of fif-
teen onwards was assumed to wear a helmet for adults.
Helmets were assumed to be replaced every 5 years, as
this is a period that is cited frequently in other bicycle
helmet research [43]. Yearly helmet costs were calcu-
lated as one fifth of these total costs. Total helmet costs
for the status quo were calculated by multiplying the
current percentage of helmet use with the total number
of cyclists. Total helmet costs under the helmet law con-
dition were calculated by multiplying the projected
helmet-wearing rate with the total number of cyclists for
each specific age group, which was then multiplied by
the mean helmet price for that age group.
Outcomes
Incremental cost-utility ratios (ICERs) were estimated by
dividing the difference in costs between the current situ-
ation and the implementation of mandatory bicycle hel-
met use, by the difference in effects between both
scenarios. This means that ICERs were estimated for re-
spectively bicycle related TBI, death, and DALYs averted.
Sensitivity analyses
One way sensitivity analysis was performed to assess the
uncertainty surrounding the following model parame-
ters: incidence of TBI, mortality, YLL, disability adjust-
ments in YLD, number of years lived with a disability,
costs of healthcare resources use, costs due to productiv-
ity loss, annual helmet costs, current helmet wearing
percentage, projected future helmet wearing percentage,
efficacy of the helmet, and total number of cyclists. The
scores were decreased and increased by 20% for each
variable separately, except for the projected helmet-
wearing rate. This variable was increased to its max-
imum value of 100%. Results of the sensitivity analyses
were displayed in tornado plots. Annual helmet costs
were varied with a factor in the range of 10–200%.
Additionally, the human-capital method was used to
calculate productivity losses for people that died due to
TBI. The use of this method assumes that productivity is
lost for the full duration of absence from work until age
of retirement, and hence, that costs of productivity
losses stretch out over a much longer period than the
friction period only [48].. These costs were calculated by
subtracting the mean age of death for the group of
working age from the retirement age of 65 years and
multiplying this with the mean amount of weeks per
year, mean working hours per week, net labor participa-
tion rate, and mean productivity costs per hour for a
working person in 2017. The same was done for the age
group younger than 15 years with the same formula, ex-
cept that they start with a full 50 years of labor left.
Discounting
Effects and costs that occurred after 1 year were dis-
counted in accordance with the Dutch guideline for eco-
nomic evaluations [26]. YLL and YLD were discounted
at a discount rate of 1.5% per year. Having TBI was as-
sumed not to influence the life expectancy for survivors
of TBI, as information about age-specific life expectancy
for TBI survivors was not available. Therefore, YLD was
discounted for the number of years that the mean per-
son within an age group was projected to live. Productiv-
ity losses for people that had died because of bicycle
related TBI were only discounted in the sensitivity ana-
lysis in which the HC-method was used, because the
friction method that was used for the base-case analysis
does not extend beyond a 1 year period. A discount rate
of 4% per year was used for all costs.
Results
Table 1 shows the values of all variables that were included
in the model. The model included 13,468,742 cyclists (see
Appendix 1 for age distribution). Implementation of a hel-
met law was projected to lead to a helmet wearing rate of
88% and helmet wearers were assumed to have a relative
risk for TBI of 0.583 (CI95 0.513–0.658).
Effects
In 2017, 8016 cases of TBI were registered in Dutch EDs
among users of utility bicycles (Table 2), of which 124
died. TBI per 100,000 inhabitants was approximately
twice as high in people of 65 years and older, compared
to other age groups. Mortality per 100,000 inhabitants
was also highest in people of 65 years and older with a
mortality rate that was fifteen and eight-fold higher than
in people under 15 years of age and people between 15
and 65 years, respectively. The total burden of TBI re-
lated disease was 11,746 DALYs (2.620 LYL and 9.126
YLD) The burden of disease relative to the incidence of
TBI was highest in people under 15 years due to a rela-
tively high number of YLD. The bottom part of Table 2
displays the projections of incidence of TBI and subse-
quent mortality for cyclists after implementation of a
helmet law.
The introduction of a helmet law is projected to lead
to a yearly reduction of 2942 cases of TBI and 46 deaths
across all age groups (Table 2). The number needed to
treat for TBI was 4029 for the overall age group. Overall
disease burden was reduced by 4310 DALYs, most of
which were averted in people between the age of 15 and
65 years (Table 2).
Costs
The decrease in TBI leads to approximate annual mean
savings of 12.8 million euros in medical costs and 11.8
million euros due to averted productivity losses.
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However, total annual depreciated spending on bicycle
helmets rose with approximately 116 million euros,
which lead to incremental cost of more than 91 million
euros (see Fig. 1).
Cost-effectiveness
Table 3 shows that there was a large fluctuation in cost-
effectiveness between the age groups, with the ICERs for
cost per TBI prevented, cost per death prevented, and
cost per DALY averted being most favourable for people
of 65 years and older, € 17,775 per DALY. Cost per TBI
and death prevented were highest for people aged 14
and younger (€ 19,152,803 and € 10,676, 247), while cost
per DALY averted was highest in the middle age group
(€ 40,519). Overall, the costs per death averted were esti-
mated at € 22,002,76, per TBI averted € 31,028, and per
Table 2 Yearly bicycle related TBI, subsequent mortality and related disease burden in the Netherlands without a helmet law (top),
with a helmet law (middle) and the difference between these scenarios (bottom). Undiscounted figures
Age TBI (n) per 100,000 Mortality (n) per 100,000 YLD(n) LYL (n) DALY (n)
Without Law
< 15 1053 38 5 0.176 2494 351 2845
15–64 4558 41 37 0.332 5408 1432 6840
≥ 65 2405 76 82 2.606 1224 837 2061
Total 8016 47 124 0.727 9126 2620 11,746
With Law
< 15 667 24 3 0.105 1579 222 1801
15–64 2885 26 23 0.215 3424 906 4330
≥ 65 1523 48 52 1.587 775 530 1305
Total 5075 30 79 0.457 5777 1658 7435
Difference
< 15 − 386 −14 −2 −0.071 − 915 − 129 − 1044
15–64 − 1673 −15 − 14 −0.117 −1985 − 525 − 2510
≥ 65 − 883 − 28 −30 − 1.019 − 449 − 307 − 756
Total −2942 − 17 −46 −0.270 − 3349 − 961 −4310
Fig. 1 Overview of total costs per scenario and spending per cost-type
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DALY € 28,465. Use of the human-capital approach for
calculating the loss of productivity leads to cost-
effectiveness estimates being approximately 10% lower
for the youngest age group and 15% lower for the middle
age group, when compared to the use of the friction-
costs method (Appendix 2).
Sensitivity analyses
The sensitivity analyses revealed that the parameter value
for helmet efficacy had the largest influence on the ICER.
A 20% increase in efficacy lowered the cost per DALY to
around € 20,000 and a 20% decrease raised the costs per
DALY to around € 42,000 for the overall group (Fig. 2).
Total number of cyclists, the annual-helmet costs and in-
cidence of TBI were additional variables that influence re-
sults to a large degree. These variables influenced the
ICER of the age group of people aged 65 years and older
sufficiently for them to possibly surpass the threshold
value of € 20,000 per DALY (Fig. 2). Pre- and post-law
helmet-wearing rates barely influenced the results. Figure 3
shows that decreasing the annual helmet costs to 2/3rd of
the standard helmet costs would also lead to cost-
effectiveness for the age groups 0–14 and 15–64 years.
Discussion
The current study aimed to assess the cost-effectiveness
of enforcing bicycle helmet use through legislation as a
means of preventing bicycle related TBI and mortality in
the Netherlands [49, 50]. Without considering different
age groups, the current intervention is not cost-effective
in light of the Dutch reference value for cost-
effectiveness of € 20,000 per QALY [50]. However, the
results show a large fluctuation in cost-effectiveness be-
tween age groups. It is notable that all ICERs are most
favorable in people aged 65 years or older, despite the
fact that this group incurred no costs for lost productiv-
ity due to retirement. The absence of savings related to
productivity losses was offset by a substantially higher
incidence rate and higher mean medical costs when
compared to the other groups (Table 2 and Appendix 3).
This age group is the only group with an ICER per
DALY averted that is below the threshold of € 20,000. In
addition, the ICER per death prevented is approximately
Table 3 Overview of incremental cost-effectiveness ratios,
friction-costs method. Discounted figures
Age per averted TBI per prevented death per averted DALY
< 15 € 49,559 € 10,676,247 € 30,217
15–64 € 35,698 € 4,401,171 € 31,856
≥65 € 14,065 € 410,871 € 17,775
Total € 31,028 € 2,002,766 € 28,465
Fig. 2 Results of one-way sensitivity analyses for the ICER of cost per DALY averted in the overall group (above) and the age group above
65 years (below)
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26 and 11 times lower as for the youngest and middle
age group, respectively.
As no Dutch utility figures for injuries associated with
traffic accidents were available, we choose to use disability
figures for injuries and DALY outcomes in our analysis. Al-
though use of DALY as an outcome measure in economic
evaluations is less common than use of QALYs, it is ac-
cepted as well, as appeared from a review of Oostvogels
et al. [51]. Therefore, the intended health effect is expressed
as DALYs averted following mandatory helmet use. Both
QALY and DALY are a form of health-adjusted life expect-
ancy (HALE). The primary difference between the two out-
come measures is that QALYs primarily measure health
gains following interventions, while DALYs measure health
losses from disease and death [52]. Another difference is
that DALYs, by adjusting life years for disability caused by
one single health problem such as TBI, do not consider co-
morbidity and thus tend to be relatively larger than QALYs
when comorbidity is present. Therefore, use of DALYs
could lead to an overestimation of the disease burden [52]
and a somewhat flattered ICER. In absence of a clear
threshold value in the Netherlands for cost-effectiveness
when DALYs are used as outcome measure, we chose to
use the same threshold value for DALYs as is commonly
used for QALYs in the Netherlands, namely € 20,000 [50].
This threshold value is much more stringent than the
WHO guidelines on cost-effectiveness that state that any
intervention with a cost-effectiveness ratio below the GDP
per capita (€ 43,100 for the Netherlands in 2017) should be
regarded as a cost-effective intervention. Should we have
followed this standard, our conclusions on cost-
effectiveness of mandatory helmet use would have been
more positive than they currently are.
When interpreting the results, it should be remem-
bered that we chose not to include the often cited sub-
stitution effect and risk compensation effect in our
analysis [53, 54] . The former is related to the fact that
mandatory helmet use could discourage current cyclists
to use bicycles but other forms of transportation instead
for (part of) their journeys [53, 54]. The latter is said to
increase risk for injury by increased risk taking behavior
by either the helmet wearing cyclists themselves or by
other traffic participants [55, 56]. However, both mecha-
nisms are not undisputed either [57]. We decided not to
include these factors in our model, due to their uncer-
tain nature. Nonetheless, we should bear in mind that
the possible presence of substitution and risk compensa-
tion effects could have led to less favorable cost-
effectiveness estimates.
Our findings are in line with the existing literature. How-
ever, most previous economic evaluations of helmet laws
have used cost-benefit methods rather than cost-
effectiveness analysis [36, 43]. Economic evaluations that
use a societal perspective of costs generally agree that a hel-
met law is not beneficial, i.e. that the costs outweigh the as-
sociated benefits [43]. Although many studies evaluate the
effectiveness of bicycle helmet laws, not many evaluate their
cost-effectiveness. To our knowledge, no contribution has
been made to this field in the last two decades. In one of
the few papers on cost-effectiveness, Hendrie et al. focused
on the cost of public education campaigns and police en-
forcement and not on medical costs and productivity losses
[38]. They did however measure the cost of purchasing hel-
mets, which was also by far their largest cost item. They es-
timated the cost per TBI prevented to be € 99,123 for their
aggregated data model and € 212,769 for their individual
Fig. 3 Cost per DALY as a function of annual helmet costs in the range of 10–200% of the standard helmet costs
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pooled data model [38]. This is substantially higher than
the €31,028 per TBI prevented that we found, probably
mainly because they did not consider the healthcare savings
associated with less TBI. In another cost-effectiveness
paper, cost per (discounted) life saved was estimated to be-
tween € 85,727 to € 110,332 for children from 5 to 12 years,
between € 673,193 to € 793,338 for children from 13 to 18
years old and between € 863,340 to € 984,404 for adults
[58]. This is substantially lower than the estimates that we
found. Interestingly, the cost per death averted in this study
is higher for adults than it is for children, while we found
an inverse relationship. The most recent cost-effectiveness
research was done in 2000 by Kopjar & Wickizer, and
found the same age gradient [59]. They found the risk of
head injury and the largest reduction in absolute risk of
head injury due to wearing a helmet to be the highest in
children. We found the opposite. Our data clearly show
that, in the Netherlands, 0.115% of all people older than 65
years had TBI in 2017, while only 0.050% of children under
15 years was admitted to an Emergency Department with
this type of trauma. This might be because the cycling in-
frastructure in the Netherlands gives this age group a feel-
ing of safety, while they are in fact more vulnerable [60]. To
our knowledge, no other research has looked at the cost
per DALY averted or QALY gained to date.
Results of the sensitivity analyses show that the ICERs
were most influenced by the efficacy of bicycle helmet use
that was assumed in the model. The efficacy of bicycle hel-
mets is often debated in the scientific literature [18, 61–63].
Generally, two types of research have been performed.
Firstly, case-control studies, in which brain damage between
people that did and did not wear a helmet is compared, and
secondly, ecological studies, in which the period before and
after the introduction of an intervention to stimulate helmet
use is compared. Case-control studies tend to find a higher
efficacy of bicycle helmets than time series analysis [64]. Both
types of research are vulnerable to confounding factors in
their own regard. The meta-analysis by Olivier et al. that was
used in this study includes recent research from several
countries over several years and was therefore the best avail-
able study [18]. Additionally, they checked for evidence of
time trends and publication bias, which they did not find.
Therefore, this meta-analysis was deemed more comprehen-
sive and likely more fitting the Dutch context, as opposed to
results from ecological studies, which generally relate to de-
velopments over time in one specific country.
In the Netherlands, the share of electric bicycles out of
all newly sold bikes rose from 15% in 2011 to 31% in
2017 [65]. According to the Dutch cyclists’ federation,
about 6% of all bicycles in the Netherlands are electric
bicycles [66]. However, more than a quarter of all bicycle
related deaths were related to use of electric bicycles.
Out of these deaths, three quarters are people aged 65
years and older [67]. The relatively high mortality under
users of electric bicycles hints to a high incidence of TBI
in this group. Therefore, users of electric bicycles seem
to be a very relevant group for the intervention under
study. Unfortunately, the EDs in the Netherlands do not
systematically register the use of an electric bicycle by
patients admitted with TBI. Hence, we could not stratify
for the use of electric bicycles in our research, while we
know that between 2010 and 2017 there was an increase
of the selling of new e-bikes of 77%.
Strengths of this study
The main strength of the study lies in the use of recent
data regarding incidence, medical costs, and disease bur-
den from the Dutch Injury Surveillance System and
Dutch Burden of Injury Model. Therefore, to our know-
ledge, this is the first paper that reports the disease bur-
den of bicycle related TBI in DALYs and the societal
costs associated with preventing them.
Limitations of this study
The availability of data used in this research restricted
us from performing probabilistic sensitivity analysis
(PSA). PSA would have resulted in more reliable and
specific ICERs by adding information about the distribu-
tion of the model parameters. However, information
about the distribution was unavailable for a large num-
ber of parameters. The probability of TBI is unrelated to
the intensity of bicycle use, while those who cycle more
are at greater exposure to TBI risk than those who rarely
use a bike. No data are available about bike use intensity.
Unfortunately, data on electric bicycles use were not
available so we could not distinguish this group of cy-
clists in this economic evaluation. The fact that we only
had healthcare costs available for the first year leads to
an underestimation of the cost-effectiveness of the use.
Finally, we did not include police enforcement and regu-
lation costs in our study, due to data limitations. The
ICERs as estimated in this study may be less beneficial
when these costs would have been taken into account.
On the other hand, the fact that we only included TBI
and not all other injury costs, such as related to frac-
tures, nor other costs of accidents, such as material dam-
age and indirect costs of traffic jams, may have
prevented us from reporting more favorable ICERs.
Our results are specific for the Dutch cycling context and,
as a consequence, not directly transferable to other countries’
settings. First, in the Netherlands cycling is much more com-
mon than in other European countries, Denmark excluded.
The infrastructure with cycle lanes and other traffic aspects,
such as right of way for cyclists and legal responsibility of
motorized traffic in any traffic accident, regardless of actual
responsibility, differs enormously from other countries. Con-
sequently, injury risks differ substantially, independent of hel-
met use. Second, in the Netherlands most cyclist currently
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do not wear a helmet, whereas in most other countries hel-
met use is common.
Conclusions
The current research shows that a law that enforces the use
of bicycle helmets for every age group is not cost-effective
with an ICER of €28,465 per DALY averted which is higher
than the accepted Dutch reference value for cost-
effectiveness of preventive interventions. With respect to the
difference between age groups, we found this intervention to
be cost-effective for people aged 65 years and over due to
their relatively high risk of getting TBI with an ICER of €17,
775 per DALY averted. One must realize that the costs of
the intervention are primarily paid by the individual citizen
and the revenues are mainly for the whole society. The ac-
quisition of helmets proved to be an important cost item. If
the price of a helmet reduces with 20%, which is a possibility
due to large-scale purchases and use of these helmets, the
introduction of this regulation would result in an interven-
tion that is approximately cost-effective for all age groups. As
this is the first study in the Netherlands that evaluates the
cost-effectiveness of enforcing helmet use for cyclists, this
can add to the debate around regulating helmet use in gen-
eral and more specifically for the elderly. We recommend fu-
ture research towards the mechanisms behind the increased
cycling risks for the elderly and the acceptability of a helmet
law. We also advise to make the registration of the use of an
electric bicycle at the ED standard practice, as the electric bi-
cycle is likely to have an increasing and significant role in
TBI. To conclude, although Dutch society is at present not
very enthusiastic to wear bicycle helmets, a law that enforces
helmet use may be an effective and also cost-effective inter-
vention, certainly in the elderly.
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